Sichuan Dowell Science and Technology Inc
Sichuan Dowell Science and Technology Inc maintains a debt-to-equity ratio of 0.29 and a current ratio of 1.46, indicating moderate liquidity and a conservative capital structure. The company's price-to-book ratio of 2.21 and price-to-tangible-book ratio of 2.21 suggest that the market values the company at a premium to its book value, while its price-to-earnings ratio of 59.14 and EV/EBITDA of 57.28 indicate a high valuation relative to earnings. Profitability metrics show a return on equity of 3.74% and a return on assets of 2.46%, both below the typical thresholds for high-performing chemical firms. The company's operating margin is 5.87% (calculated from operating income of 41.87 million CNY on revenue of 712.82 million CNY), which is lower than the median for the Commodity Chemicals industry. Gross margin of 39.07% (278.53 million CNY on 712.82 million CNY revenue) is in line with industry norms. The company's revenue is distributed across domestic and international markets, with notable exposure to Vietnam, Bangladesh, Ethiopia, Mongolia, and Thailand. However, the financial data does not provide a breakdown of revenue by region or segment, limiting visibility into geographic concentration risk. Growth prospects are constrained, with no specific revenue growth rates provided in the latest financials. The company reported a net income of 35.81 million CNY on revenue of 712.82 million CNY, with a free cash flow of -16.82 million CNY, indicating that capital expenditures of 89.54 million CNY exceeded operating cash flow of 70.81 million CNY. This suggests a capital-intensive business model with limited cash generation. The risk assessment highlights a medium liquidity risk due to negative net cash after subtracting total debt. Dilution risk is assessed as low, with no significant dilution sources identified in the latest filings. The company's capital structure remains stable, with long-term debt of 280.25 million CNY and total liabilities of 497.25 million CNY. Recent financial filings and transcripts do not indicate any material events or strategic shifts. The company's last actual EPS was 0.38 CNY, according to analyst estimates, which is consistent with the net income of 35.81 million CNY and 107.02 million shares outstanding.
Business. Sichuan Dowell Science and Technology Inc develops, produces, and sells leather chemicals, including enzyme preparations, degreasers, bactericidal mold inhibitors, and finishing materials, primarily for domestic and international markets such as Vietnam, Bangladesh, Ethiopia, Mongolia, and Thailand.
Classification. The company is classified under the Basic Materials economic sector, Chemicals business sector, and Commodity Chemicals industry, with a confidence level of 0.92 based on verified market data.
- Sichuan Dowell Science and Technology Inc has a high valuation multiple (P/E of 59.14, EV/EBITDA of 57.28) despite relatively low profitability (ROE of 3.74%, ROA of 2.46%).
- The company's capital structure is conservative, with a debt-to-equity ratio of 0.29 and a current ratio of 1.46, but free cash flow is negative due to high capital expenditures.
- Revenue is distributed across domestic and international markets, but the financial data does not provide a detailed breakdown of geographic exposure.
- Growth is limited, with no specific revenue growth rates provided, and the company is capital-intensive with limited cash generation.
- Liquidity risk is moderate, and dilution risk is low, with no significant dilution sources identified in the latest filings.
- --
- ## RATIONALES
- ```json
- Net cash is negative after subtracting total debt.